(S1 (S (NP (NP (JJ Federal) (NN drug) (NNS regulators)) (, ,) (VP (VBN concerned) (PP (IN over) (NP (NP (JJ British) (NNS reports)) (SBAR (WHNP (IN that)) (S (NP (NNS diabetics)) (VP (VBP have) (VP (VBN died) (PP (IN after) (S (VP (VBG shifting) (PP (PP (IN from) (NP (NN animal))) (PP (TO to) (NP (JJ human-based) (NN insulin)))))))))))))) (, ,)) (VP (VBP say) (SBAR (S (NP (PRP they)) (VP (VBP are) (VP (VBG considering) (NP (NP (DT a) (NN study)) (SBAR (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (JJ similar) (NNS deaths)) (VP (VBP have) (VP (VBN occurred) (ADVP (RB here)))))))))))))))) (. .)))

(S1 (S (NP (DT The) (NNP United) (NNP Kingdom) (NNS reports)) (VP (VBD came) (PP (IN from) (NP (NP (NNP Dr.) (NNP Patrick) (NNP Toseland)) (, ,) (NP (NP (NN head)) (PP (IN of) (NP (JJ clinical) (NN chemistry))) (PP (IN at) (NP (NP (NP (NNP Guy) (POS 's)) (NNP Hospital)) (PP (IN in) (NP (NNP London))))))))) (. .)))

(S1 (S (PP (IN In) (NP (DT a) (NN telephone) (NN interview))) (NP (NNP Friday)) (, ,) (NP (NNP Dr.) (NNP Toseland)) (VP (VBD said) (SBAR (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ sudden) (, ,) (JJ unexplained) (NNS deaths)) (PP (IN of) (NP (NP (NNS diabetics)) (SBAR (S (NP (PRP he)) (VP (VBD had) (VP (VBN seen) (NP (DT this) (NN year))))))))))) (VP (VBD was) (NP (CD 17)) (PP (VBN compared) (PP (IN with) (NP (NP (QP (RB just) (CD two))) (PP (IN in) (NP (CD 1985)))))))))) (. .)))

(S1 (S (S (NP (NP (QP (IN At) (JJS least) (CD six))) (PP (IN of) (NP (DT the) (NNS deaths)))) (VP (VBD occurred) (PP (IN among) (NP (NP (RB relatively) (JJ young) (NNS diabetics)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN switched) (PP (PP (IN from) (NP (NN animal))) (PP (TO to) (NP (NP (JJ human) (NN insulin)) (PP (IN within) (NP (DT the) (JJ past) (NN year)))))))))))))) (, ,) (NP (PRP he)) (VP (VBD said)) (. .)))

(S1 (S (NP (NP (NNP Dr.) (NNP Solomon) (NNP Sobel)) (, ,) (NP (NP (NN director)) (PP (IN of) (NP (NN metabolism) (CC and) (NN endrocrine) (NN drug) (NNS products))) (PP (IN for) (NP (DT the) (NNP U.S.) (NNP Food) (CC and) (NNP Drug) (NNP Administration)))) (, ,)) (VP (VBD said) (SBAR (S (NP (NNP FDA) (NNS officials)) (VP (VBP have) (VP (VBN discussed) (S (NP (NP (NNP Dr.) (NNP Toseland) (POS 's)) (NNS findings)) (`` `) (ADJP (`` `) (RB fairly) (JJ intensively)))))))) (. .) ('' ') ('' ')))

(S1 (S (SBAR (IN While) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (NNS reports)) (PP (IN of) (NP (JJ similar) (ADJP (JJ sudden) (JJ unexplained)) (NNS deaths)))) (PP (IN among) (NP (NP (NNS diabetics)) (PP (IN in) (NP (DT the) (NNP U.S.))))))))) (, ,) (NP (NNP Dr.) (NNP Sobel)) (VP (VBD said) (SBAR (S (NP (DT the) (NNP FDA)) (VP (VP (VBZ plans) (S (VP (TO to) (VP (VB examine) (NP (NP (NNP Dr.) (NNP Toseland) (POS 's)) (NN evidence)))))) (CC and) (VP (VBZ is) (VP (VBG considering) (NP (PRP$ its) (JJ own) (NN study)) (ADVP (RB here)))))))) (. .)))

(S1 (S (NP (NP (NNP Dr.) (NNP Toseland)) (, ,) (NP (DT a) (NN toxicologist)) (, ,)) (VP (VBD said) (SBAR (S (NP (PRP he)) (VP (VBD was) (VP (VBG preparing) (NP (DT an) (NN article)) (PP (IN for) (NP (NP (DT a) (JJ British) (JJ forensic) (JJ medical) (NN journal)) (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (DT the) (NNS deaths)) (VP (MD may) (VP (VB have) (VP (VBN occurred) (PP (IN after) (NP (NP (JJ human) (NN insulin)) (VP (VBN blunted) (NP (NP (JJ critical) (NN warning) (NNS signs)) (VP (VBG indicating) (NP (NP (NN hypoglycemia)) (, ,) (CC or) (NP (JJ low) (NN blood) (NN sugar)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB kill) (NP (NNS diabetics)))))))))))))))))))))) (. .)))

(S1 (S (NP (NP (DT The) (JJ usual) (NN warning) (NNS signs)) (PP (IN of) (NP (NN hypoglycemia)))) (VP (VBP include) (S (VP (VBG sweating) (, ,) (UCP (NN anxiety) (CC and) (NNS cramps))))) (. .)))

(S1 (S (PP (IN With) (NP (JJ proper) (NN warning))) (, ,) (NP (NNS diabetics)) (VP (MD can) (ADVP (RB easily)) (VP (VB raise) (NP (PRP$ their) (NN blood) (NN sugar)) (PP (TO to) (NP (JJ safe) (NNS levels))) (PP (IN by) (S (VP (VBG eating) (NP (NN sugar) (CC or) (NN sugary) (NN food))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (DT The) (JJ anecdotal) (NN data)) (ADVP (RB certainly)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS people)))) (VP (VBD were) (RB not) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (JJ rapid) (NN onset)) (PP (IN of) (NP (NN hypoglycemia)))))))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Toseland)) (VP (VBD said)) (. .)))

(S1 (S (PP (IN At) (NP (NP (DT the) (NNP U.S.) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health))))) (, ,) (NP (NP (NNP Dr.) (NNP Robert) (NNP E.) (NNP Silverman)) (, ,) (NP (NP (NN chief)) (PP (IN of) (NP (DT the) (NN diabetes) (NN program) (NN branch)))) (, ,)) (VP (VBD said) (SBAR (S (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (JJ unexpected) (NNS deaths)) (PP (IN from) (NP (NN hypoglycemia)))))) (VP (VBD had) (VP (VBN shown) (PRT (RP up)) (PP (IN in) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (CD 1,500) (NNS diabetics)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (PP (IN under) (NP (NP (NN way)) (PP (IN at) (NP (NNP NIH))))) (PP (IN for) (NP (CD five) (NNS years)))))))))))))))) (. .)))

(S1 (S (ADVP (RB However)) (, ,) (NP (PRP he)) (VP (VBD said) (SBAR (S (NP (NP (NNS officials)) (VP (VBG conducting) (NP (DT the) (NN study)))) (VP (VBD had) (RB n't) (VP (VBN been) (VP (VBG looking) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NNS problems)) (VP (VBN related) (PP (TO to) (NP (NN hypoglycemia) (NN unawareness)))))))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP We)) (VP (VBP are) (ADVP (RB now)) (VP (VBG monitoring) (PP (IN for) (NP (PRP it))) (ADVP (RB much) (RBR more) (RB closely)))) (, ,) ('' ')) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP We)) (VP (VBP do) (VP (VB know) (SBAR (S (NP (EX there)) (VP (VBP are) (NP (NP (JJ slight) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN way)) (SBAR (S (NP (UCP (NN human) (CC and) (NN animal)) (NNS insulins)) (VP (VBP drive) (PRT (RP down)) (NP (NN blood) (NN sugar))))))))))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Sobel)) (VP (VBD said)) (. .)))

(S1 (S (S (NP (DT The) (JJ human-based) (NN drug)) (VP (VP (VBZ starts) (S (NP (DT the) (NN blood) (NN sugar)) (VP (VBG dropping) (ADVP (RBR sooner))))) (CC and) (VP (VBZ drives) (S (NP (PRP it)) (ADVP (RB down) (ADVP (RBR faster))))))) (, ,) (NP (PRP he)) (VP (VBD said)) (. .)))

(S1 (S (`` `) (S (`` `) (CC But) (NP (PRP we)) (VP (VBP do) (RB n't) (VP (VB believe) (SBAR (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ enough)) (PP (IN of) (NP (NP (DT a) (NN difference)) (SBAR (S (VP (TO to) (VP (VB be) (ADJP (RB clinically) (JJ significant)))))))))))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Sobel)) (VP (VBD said)) (. .)))

(S1 (S (NP (NP (NNS Reports)) (PP (IN of) (NP (NP (NP (NNP Dr.) (NNP Toseland) (POS 's)) (NNS findings)) (PP (IN in) (NP (DT the) (JJ British) (NN press)))))) (VP (VBP have) (VP (VBN triggered) (NP (NP (JJ widespread) (NN concern)) (PP (IN among) (NP (NP (NNS diabetics)) (ADVP (RB there))))))) (. .)))

(S1 (S (NP (DT Both) (NP (DT the) (NNP British) (NNP Diabetic) (NNP Association)) (CC and) (NP (NP (DT the) (NNP Committee)) (PP (IN on) (NP (NP (NNP Safety)) (PP (IN in) (NP (NP (NNS Medicines)) (: --) (NP (NP (NP (NNP Britain) (POS 's)) (NN equivalent)) (PP (IN of) (NP (DT the) (NNP U.S.) (NNP FDA)))) (: --))))))) (ADVP (RB recently)) (VP (VBD issued) (NP (NP (NNS statements)) (VP (VBG noting) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (JJ hard) (JJ scientific) (NN evidence)))) (S (VP (TO to) (VP (VB support) (NP (NP (NNP Dr.) (NNP Toseland) (POS 's)) (NNS findings)))))))) (. .)))

(S1 (S (PP (IN On) (NP (NNP Friday))) (, ,) (NP (DT the) (JJ American) (NN Diabetes) (NN Association)) (VP (VBD issued) (NP (NP (DT a) (JJ similar) (NN statement)) (VP (VBG urging) (NP (DT the) (QP (CD six) (CD million)) (NNP U.S.) (NNS diabetics)) (S (RB not) (VP (TO to) (VP (VB overreact) (PP (TO to) (NP (DT the) (JJ British) (NN report))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (NP (DT A) (NN loss)) (PP (IN of) (NP (NP (DT the) (VBG warning) (NNS symptoms)) (PP (IN of) (NP (NN hypoglycemia)))))) (VP (VBZ is) (NP (NP (DT a) (JJ complex) (NN problem)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (RB very) (JJ unlikely)) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (RB simply) (PP (TO to) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NN insulin))) (VP (VBN used))))))))))))) (, ,) ('' ')) ('' ') (NP (DT the) (NNP American) (NN association)) (VP (VBD said)) (. .)))

(S1 (S (NP (DT The) (NNP FDA)) (ADVP (RB already)) (VP (VBZ requires) (S (NP (NN drug) (NNS manufacturers)) (VP (TO to) (VP (VB include) (NP (NP (NNS warnings)) (PP (IN with) (NP (NN insulin) (NNS products))) (SBAR (IN that) (S (NP (NP (NNS symptoms)) (PP (IN of) (NP (NN hypoglycemia)))) (VP (VBP are) (ADJP (ADJP (RBR less) (JJ pronounced) (PP (IN with) (NP (JJ human) (NN insulin)))) (PP (IN than) (PP (IN with) (NP (JJ animal-based) (NNS products))))))))))))) (. .)))

(S1 (S (NP (NP (NNP Eli) (NNP Lilly) (CC &) (NNP Co.)) (, ,) (NP (DT the) (JJ Indianapolis-based) (NN drug) (NN manufacturer)) (, ,)) (VP (VBZ dominates) (NP (DT the) (NNP U.S.) (JJ human) (NN insulin) (NN market)) (PP (IN with) (NP (NP (PRP$ its) (NN product)) (VP (VBN known) (PP (IN as) (NP (NNP Humulin))))))) (. .)))

(S1 (S (NP (NNP Lilly)) (VP (VBZ is) (VP (VBG building) (NP (NNS plants)) (S (VP (TO to) (VP (VB make) (NP (NP (DT the) (NN insulin)) (PP (IN in) (NP (NP (NNP Indianapolis)) (CC and) (NP (NP (NNP Fagershein)) (, ,) (NP (NNP France))))))))))) (. .)))

(S1 (S (PP (IN In) (NP (PRP$ its) (JJS latest) (JJ annual) (NN report))) (, ,) (NP (NNP Lilly)) (VP (VBD said) (SBAR (S (NP (NNP Humulin) (NNS sales)) (VP (VBP have) (VP (VBN shown) (S (`` `) (NP (`` `) (JJ excellent) (NN growth)))))))) (. .) ('' ') ('' ')))

(S1 (S (NP (NNP Lilly) (NNS officials)) (VP (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBD had) (VP (VBN seen) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ hypoglycemic) (NN unawareness)))) (PP (IN among) (NP (NP (DT some) (NNS patients)) (VP (VBG making) (NP (DT the) (NN shift)) (PP (PP (IN from) (NP (NN animal))) (PP (TO to) (NP (JJ human) (NN insulin)))))))))))) (, ,) (CC but) (VP (VBD did) (RB n't) (VP (VB know) (SBAR (IN if) (S (NP (DT the) (NN problem)) (VP (VBD had) (VP (VBN caused) (NP (DT any) (NNS deaths))))))))) (. .)))

(S1 (S (NP (NP (NNP Dr.) (NNP Leigh) (NNP Thompson)) (, ,) (NP (DT a) (NNP Lilly) (NN group) (NN vice) (NN president)) (, ,)) (VP (VBD said) (SBAR (S (NP (NP (NP (DT the) (NN company) (POS 's)) (JJ clinical) (NNS trials)) (PP (IN of) (NP (DT both) (PRP$ its) (UCP (NN animal) (CC and) (JJ human-based)) (NNS insulins)))) (VP (VBD indicated) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN hypoglycemia))))) (PP (IN between) (NP (NP (NNS users)) (PP (IN of) (NP (DT either) (NN product)))))))))) (. .)))

(S1 (S (NP (NNP Dr.) (NNP Toseland)) (VP (VBD said) (SBAR (S (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (JJ British) (NNS diabetics)) (SBAR (WHNP (WP who)) (S (VP (VBD died))))))) (VP (VBD had) (VP (VBN been) (VP (VBG taking) (NP (NP (DT a) (JJ human-based) (NN insulin)) (VP (VBN made) (PP (IN by) (NP (NP (NNP Novo\/Nordisk)) (, ,) (NP (DT a) (JJ Danish) (NN manufacturer)))))))))))) (. .)))

(S1 (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS diabetics)))) (VP (VBD were) (VP (VBG using) (NP (NP (NNP Lilly) (POS 's)) (NN insulin)))) (. .)))

